
| 67392-87-4 | Drospirenone | LocaI GMP/DMF |
| 84371-65-3 | Mifepristone | China-GMP/EU-DMF |
| 68-22-4 | Norethisterone | CEP/DMF |
| 51-98-9 | Norethisterone acetate | Local GMP/DMF |
| 3836-23-5 | Norethisterone enanthate | Cofepris/DMF |
| 57-83-0 | Progesterone* | DMF |
| 71-58-9 | Medroxyprogesterone Acetate | TDP |
| 126784-99-4 | Ulipristal acetate | R&D |
| 58691-88-6 | Normegestrel | R&D |
| 5630-53-5 | Tibolone | CEP |
| 54024-22-5 | Desogestrel | R&D |
| 54048-10-1 | Etonogestrel | R&D |
| 152-62-5 | Dydrogesterone | R&D |
| 850-52-2 | Altrenogest* | DMF Undergoing |

57-63-6 | Ethynylestradiol | DMF/Japan-GMP |
50-28-2 | Estradiol | DMF |
35380-71-3 | Estradiol hemihydrate | DMF |
4956-37-0 | Estradiol enanthate | Cofepris/DMF |
979-32-8 | Estradiol valerate | Cofepris/DMF |
50-50-0 | Estradiol benzoate | Upon request |
313-06-4 | Estradiol cypionate | Upon request |
50-27-1 | Estriol | Upon request |

1950/2/2 | Dexamethasone | TDP |
2392-39-4 | Dexamethasone sodium phosphate* | Veterinary China-GMP |
50-23-7 | Hydrocortisone | TDP |
1950/3/3 | Hydrocortisone acetate | TDP |
1953/3/2 | Prednisone | Upon request |
50-24-8 | Prednisolone | Upon request |
52-21-1 | Prednisolone acetate | Upon request |
83-43-2 | Methylprednisolone | Upon request |
14484-47-0 | Deflazacort | Mexico GMP/DMF/Cofepris/DMF |
2135-17-3 | Fluticasone propionate | TDP |
397864-44-7 | Fluticasone furoate | TDP |
107724-20-9 | Eplerenone | R&D |
13647-35-3 | Trilostane* | DMF Undergoing |

129453-61-8 | Fulvestrant | R&D |
154229-18-2 | Abiraterone acetate | DMF |
53-16-7 | D7/Q4 | TDP |
82543-16-6 | D8/Q5 | DMF |
84371-64-2 | 3-Ethylene dioxy-17-oxo-13β-methyl estra-5(10)9(11)-diene | TDP |
5571-36-8 | Ethylene deltenone | TDP |
3962-66-1 | 19-Nor-5(10)-androstene-3,17-dione | TDP |
5173-46-6 | Estra-4,9-diene-3,17-dione | TDP |
734-32-7 | 19-Nor-4-androstene-3,17-dione | TDP |
68-96-2 | 17a-Hydroxyprogesterone | TDP |
302-23-8 | 17a-Hydroxyprogesterone Acetate | TDP |
211-138-8 | 17a-Hydroxyprogesterone caproate | Prepare on demand/Upon request |
54201-84-2 | 3,20-Bis(ethylenedioxy)-19- norpregna-5(10),9(11)-dien-17-ol | TDP |
31981-44-9 | Gestonorone acetate/ 17a-hydroxy- 19-norprogesterone-17-acetate | TDP |
88247-84-1 | 7α-Methyl-3,3-dimethoxy-5(10)- estrene-17-one | DMF |
54024-21-4 | 11-methylene-18-methyl-Estra-4-ene- 17-one | R&D |
53067-82-6 | 11α-hydroxy-18-methyl-Estra-4-en- 3,17-dione | R&D |
68917-50-0 | 18-methyl-3-methoxy-2,5(10)- estradiene-17-ol | R&D |
81968-78-7 | 3-hydroxy-5,7-pregnadien-20-one | TDP |
19592-55-3 | 3,20-Bis(ethylenedioxy)pregna-5,7-diene | TDP |
53-16-7 | Estrone | DMF |
510-64-5 | 19-Hydroxy a ndrost-4-ene-3,17-dione | DMF |
24916-90-3 | 8DM; 16α-methyl epoxide | TDP |
1035-69-4 | 9-Dehydroandrostenedione | TDP |
7753-60-8 | Anecortave acetate;H6 | TDP |
2135-17-3 | Flumethasone | TDP |
28416-82-2 | Flumethasone acid | TDP |
192569-17-8 | 11α-Hydroxy canrenon | TDP |
192704-56-6 | 11α-Hydroxy canrenone methyl ester | TDP |
2590-41-2 | 6-Dehydronandrolone acetate | TDP |
571-92-6 | 6-keto estradiol | TDP |
875573-69-6 | Fulvestrant intermediate N-3 | TDP |
153004-31-0 | Fulvestrant intermediates N-2 | R&D |
154229-19-3 | Abiraterone / (3β)-17-(Pyridin-3-yl)-androsta-5,16-dien-3-ol | TDP |
32138-69-5 | Iodine DHEA/ 17-lodoandrost - 5.16- dien-3β-oL | TDP |
853-23-6 | Prasterone Acetate | US-FDA approved |
53-43-0 | DHEA | DMF |